Lab-Grown brain cells transplanted to fight Parkinson's
NCT ID NCT06422208
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This early-stage trial tests the safety of transplanting dopamine neurons made from a patient's own stem cells into the brain to treat Parkinson's disease. Six people with Parkinson's will receive the transplant and be monitored for side effects and motor function changes. The goal is to see if this approach is safe enough to move to larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham & Women's Hospital
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.